‘America’s Other Drug Problem’: Copious Prescriptions For Hospitalized Elderly
(By Anna Gorman for Kaiser Health News) SANTA MONICA, Calif. — Dominick Bailey sat at his computer, scrutinizing the medication
Read More
Part D/Prescription Drugs
Behind the stealth ad campaigns for the EpiPen and other drugs
(By Rebecca Robbins for ST A T) M ylan Pharmaceuticals has spent millions this year on television ads and celebrity
Read MoreIn Boston’s ‘Safe Space,’ Surprising Insights Into Drug Highs
(By Martha Bebinger, WBUR for Kaiser Health News) Some arrive on their own, worried about what was really in that
Read MoreSenators want to know what FDA is doing to make EpiPen rivals available
(By Ed Silverman for ST A T) W hile anger is directed at Mylan Pharmaceuticals over the rising cost of
Read MoreTaking a look at one attempt to rein in the EpiPen cost problem
As the finger-pointing and public outrage rages on over EpiPen pricing, Mylan recently announced plans to offer discounts, via coupon,
Read MoreIllegally Made Fentanyl Seems To Be Fueling A Spike In Overdoses
(By Katherine Hobson for NPR) Federal data suggest illegally manufactured fentanyl, a drug that is 50 to 100 times stronger
Read MoreReport For State Insurance Commissioners Offers Options To Improve Drug Access
(By Michelle Andrews for Kaiser Health News) As prescription drug costs continue to rise, ensuring that consumers have access to
Read MoreMost experts who develop cancer treatment guidelines have ties to industry
(By Ed Silverman for ST A T) A s cancer treatments become both more innovative and costlier, a new study
Read MoreUnder fire, Mylan takes steps to make $600 EpiPen more affordable
(Ed Silverman for ST A T) I n the face of withering criticism , Mylan Pharmaceuticals took steps Thursday to
Read MoreGovernment-Protected ‘Monopolies’ Drive Drug Prices Higher, Study Says
(By Sydney Lupkin for Kaiser Health News) The “most important factor” that drives prescription drug prices higher in the United
Read More